European Medicines Agency fees

This procedure establishes the fees that pharmaceutical companies must pay to the European Medicines Agency (EMA). These charges help fund the agency's work in evaluating and monitoring medicines to ensure they are safe and effective for use across the European Union.

This primarily affects pharmaceutical companies and developers who apply for marketing authorizations or other regulatory services within the EU.